Product Information
GLIPIZIDE-METFORMIN 2.5-250 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3003 per EA under NDC 00093745501. Its NADAC has been published 505 times since Nov 28, 2013.
Strength
2.5; 250 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093745501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077270On Market Since
10/28/2005
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has been published 505 times since Nov 28, 2013, and over the history we have for it it has declined 21.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3003 per EA |
|---|---|
| All-time high | $0.5578 (Mar 16, 2016) |
| All-time low | $0.1748 (Nov 19, 2025) |
| 52-week high | $0.3003 |
| 52-week low | $0.1748 |
| Median price | $0.3385 |
| Average price | $0.3583 |
| Largest weekly change | -42.2% (Oct 17, 2018) |
| Weeks tracked | 505 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIPIZIDE-METFORMIN 2.5-250 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 2.5-250 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.3003 per EA (NDC 00093745501), effective Jun 24, 2026.
How has the price of GLIPIZIDE-METFORMIN 2.5-250 MG changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has declined 21.6%. It has been tracked across 505 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 2.5-250 MG?
Since Nov 28, 2013, the NADAC for GLIPIZIDE-METFORMIN 2.5-250 MG has ranged from a low of $0.1748 (Nov 19, 2025) to a high of $0.5578 (Mar 16, 2016), with a median of $0.3385 per EA.
Are there cheaper alternatives to GLIPIZIDE-METFORMIN 2.5-250 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GLIPIZIDE-METFORMIN 2.5-250 MG, but none are currently priced below it.
Who manufactures GLIPIZIDE-METFORMIN 2.5-250 MG?
GLIPIZIDE-METFORMIN 2.5-250 MG (NDC 00093745501) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification